CompletedNot Applicable

Hyperbaric Oxygen Therapy for Treatment of Severe Radiation-Induced Complications

Slovenia39 participantsStarted 2016-05-19

Plain-language summary

This study evaluates the safety and effectiveness of hyperbaric oxygen therapy (HBOT) for the treatment of severe radiation-induced complications in patients previously treated with radiotherapy. Patients with clinically significant late radiation injuries will undergo HBOT sessions in a hyperbaric chamber. The study aims to assess clinical improvement of radiation damage and overall treatment tolerance.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients (≥18 years) * History of radiotherapy * Clinically significant radiation-induced complications requiring hyperbaric oxygen therapy * Ability to provide written informed consent Exclusion Criteria: * Contraindications to hyperbaric oxygen therapy (e.g., untreated pneumothorax) * Severe comorbidity preventing safe HBOT treatment * Inability to tolerate hyperbaric chamber sessions * Withdrawal of informed consent

What they're measuring

Reduction of severe radiation-induced tissue damage

Timeframe: Up to 3 months after completion of HBOT treatment

Trial details

NCT IDNCT07422168

SponsorInstitute of Oncology Ljubljana

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-31

View on ClinicalTrials.gov More Radiation Injury trials